Brooks Laboratories Quarterly Results for Trading Insights
BROOKS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹8 Cr
QSept 2025
Brooks Laboratories Quarterly Results Key Highlights
- Revenue of ₹30 Cr in Sept 2025 (+25.0% vs Mar 2025, +42.9% vs Sept 2024)
- Net Profit of ₹8 Cr in Sept 2025 (+500.0% vs Mar 2025, +300.0% vs Sept 2024)
- EBITDA of ₹9 Cr in Sept 2025 (+1000.0% vs Mar 2025)
- Operating Margin of 11.0% in Sept 2025 (+16.0pp vs Mar 2025)
- Earnings Per Share of ₹2.71 in Sept 2025 (+601.9% vs Mar 2025)
Brooks Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 30 | 24 | 33 | 21 | 18 | 25.0% | 42.9% |
| Net Profit (₹ Cr) | 8 | -2 | 10 | -4 | -10 | - | - |
| EBITDA (₹ Cr) | 9 | -1 | 10 | -3 | -9 | - | - |
| EPS (₹) | 2.71 | -0.54 | 3.25 | -1.51 | -3.77 | - | - |
| Operating Margin (%) | 11.0% | -5.0% | 12.0% | -16.0% | -54.0% | - | - |
Brooks Laboratories Share Price Trend Around Quarterly Results
Visualize Brooks Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Brooks Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Brooks Laboratories
Additional stock information and data for BROOKS
Revenue Trend (₹ Cr)
Sept 2024
21
Jun 2025
33
Mar 2025
24
Sept 2025
30
Net Profit Trend (₹ Cr)
Sept 2024
-4
Jun 2025
10
Mar 2025
-2
Sept 2025
8
Operating Margin Trend (%)
Sept 2024
-16.0%
Jun 2025
12.0%
Mar 2025
-5.0%
Sept 2025
11.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Brooks Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores